Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1995 1
1997 1
1999 1
2004 1
2009 1
2010 2
2011 1
2012 1
2013 2
2014 3
2015 4
2016 4
2017 2
2018 2
2019 1
2020 4
2021 3
2022 2
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Current and investigational drug strategies for glioblastoma.
Ajaz M, Jefferies S, Brazil L, Watts C, Chalmers A. Ajaz M, et al. Among authors: brazil l. Clin Oncol (R Coll Radiol). 2014 Jul;26(7):419-30. doi: 10.1016/j.clon.2014.03.012. Epub 2014 Apr 24. Clin Oncol (R Coll Radiol). 2014. PMID: 24768122 Review.
Active dendritic cell immunotherapy for glioblastoma: Current status and challenges.
Polyzoidis S, Tuazon J, Brazil L, Beaney R, Al-Sarraj ST, Doey L, Logan J, Hurwitz V, Jarosz J, Bhangoo R, Gullan R, Mijovic A, Richardson M, Farzaneh F, Ashkan K. Polyzoidis S, et al. Among authors: brazil l. Br J Neurosurg. 2015 Apr;29(2):197-205. doi: 10.3109/02688697.2014.994473. Epub 2014 Dec 26. Br J Neurosurg. 2015. PMID: 25541743 Review.
MGMT Promoter Methylation: Prognostication beyond Treatment Response.
Ashkan K, Baig Mirza A, Soumpasis C, Syrris C, Kalaitzoglou D, Sharma C, James ZJ, Khoja AK, Ahmed R, Vastani A, Bartram J, Chia K, Al-Salihi O, Swampilai A, Brazil L, Laxton R, Reisz Z, Bodi I, King A, Gullan R, Vergani F, Bhangoo R, Al-Sarraj S, Lavrador JP. Ashkan K, et al. Among authors: brazil l. J Pers Med. 2023 Jun 14;13(6):999. doi: 10.3390/jpm13060999. J Pers Med. 2023. PMID: 37373988 Free PMC article.
A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial.
Bhaskaran D, Savage J, Patel A, Collinson F, Mant R, Boele F, Brazil L, Meade S, Buckle P, Lax S, Billingham L, Short SC. Bhaskaran D, et al. Among authors: brazil l. BMC Cancer. 2024 Jan 15;24(1):83. doi: 10.1186/s12885-023-11792-4. BMC Cancer. 2024. PMID: 38225549 Free PMC article.
Patient-reported Experience Measure for Neuro-oncology Telephone Clinics during the COVID-19 Pandemic.
Ghimire P, Lavrador JP, Onyiriuka L, Robinson C, La J, Mullens L, Hurwitz V, Cikurel K, Al-Salihi O, Swampillai A, Brazil L, Bhangoo R, Vergani F, Gullan R, Ashkan K. Ghimire P, et al. Among authors: brazil l. Clin Oncol (R Coll Radiol). 2021 Jan;33(1):e87. doi: 10.1016/j.clon.2020.08.004. Epub 2020 Aug 20. Clin Oncol (R Coll Radiol). 2021. PMID: 32828636 Free PMC article. No abstract available.
Overcoming challenges of translating deep-learning models for glioblastoma: the ZGBM consortium.
Shuaib H, Barker GJ, Sasieni P, De Vita E, Chelliah A, Andrei R, Ashkan K, Beaumont E, Brazil L, Rowland-Hill C, Lau YH, Luis A, Powell J, Swampillai A, Tenant S, Thust SC, Wastling S, Young T, Booth TC; ZGBM consortium. Shuaib H, et al. Among authors: brazil l. Br J Radiol. 2023 Jan 1;96(1141):20220206. doi: 10.1259/bjr.20220206. Epub 2022 Nov 1. Br J Radiol. 2023. PMID: 35616700 Free PMC article.
Has the survival of patients with glioblastoma changed over the years?
deSouza RM, Shaweis H, Han C, Sivasubramaniam V, Brazil L, Beaney R, Sadler G, Al-Sarraj S, Hampton T, Logan J, Hurwitz V, Bhangoo R, Gullan R, Ashkan K. deSouza RM, et al. Among authors: brazil l. Br J Cancer. 2016 Jan 19;114(2):146-50. doi: 10.1038/bjc.2015.421. Epub 2015 Dec 15. Br J Cancer. 2016. PMID: 26671748 Free PMC article.
Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG).
Preusser M, Silvani A, Le Rhun E, Soffietti R, Lombardi G, Sepulveda JM, Brandal P, Brazil L, Bonneville-Levard A, Lorgis V, Vauleon E, Bromberg J, Erridge S, Cameron A, Lefranc F, Clement PM, Dumont S, Sanson M, Bronnimann C, Balaná C, Thon N, Lewis J, Mair MJ, Sievers P, Furtner J, Pichler J, Bruna J, Ducray F, Reijneveld JC, Mawrin C, Bendszus M, Marosi C, Golfinopoulos V, Coens C, Gorlia T, Weller M, Sahm F, Wick W. Preusser M, et al. Among authors: brazil l. Neuro Oncol. 2022 May 4;24(5):755-767. doi: 10.1093/neuonc/noab243. Neuro Oncol. 2022. PMID: 34672349 Free PMC article. Clinical Trial.
32 results